#1
#1 out of 186.5K est. views
health9h ago
A woman's cancer seemed incurable. Identifying a rare genetic condition saved her life.
- Diane Davis's advanced ovarian cancer was initially deemed incurable before molecular testing revealed Lynch syndrome.
- Lynch syndrome increases cancer risk and helps explain Davis's family history of cancer.
- Checkpoint inhibitors were used after genetic testing, enabling the immune system to target cancer.
- Davis received pembrolizumab every three weeks and saw rapid tumor reduction.
- Within two treatments, a newly identified pelvic mass disappeared and lymph node cancer receded.
- Davis's Lynch syndrome diagnosis prompted her daughter to start early cancer screenings.
- Davis has remained in complete remission for six years following treatment.
- The case demonstrates how molecular testing can reframe prognosis and guide options.
- Davis credits immunotherapy for restoring her health after chemotherapy failure.
Vote 0